Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit

Pediatric Infectious Disease Journal

Volumn 30, Issue 4, 2011, Pages 273-278

  Chiu, Chia Hua ^a,b   Michelow, Ian C ^c,d   Cronin, Jonathan ^c,d   Ringer, Steven A ^d   Ferris, Timothy G ^c,d   Puopolo, Karen M ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ELMHURST HOSPITAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antibiotic stewardship; Infection control; Neonatal intensive care unit; Newborn; Vancomycin restriction

Indexed keywords

AMPHOTERICIN; AMPICILLIN; CEPHALOSPORIN; CLINDAMYCIN; GENTAMICIN; MEROPENEM; METRONIDAZOLE; NAFCILLIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; DRUG USE; HUMAN; INFANT; INFANT MORTALITY; INFECTION; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; NEWBORN INTENSIVE CARE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 79954756925     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182011d12     Document Type: Article

References (24)

1. Stoll BJ, Hansen NI, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics. 2002;110:285-291. (Pubitemid 34833012)
2. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357-2365. (Pubitemid 39491920)
3. Venkatesh MD, Placenia F, Weisman LE. Coagulase-negative staphylococcal infections in the neonate and child: an update. Semin Pediatr Infect Dis. 2006;17:120-127. (Pubitemid 44278616)
4. Duchon J, Graham IP, Della-Latta P, et al. Epidemiology of enterococci in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2008;29:374-376. (Pubitemid 351416992)
5. Linkin DR, Fishman NO, Patel JB, et al. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2004;25:781-783. (Pubitemid 39312052)
6. Singh N, Léger MM, Campbell J, et al. Control of vancomycin-resistant enterococci in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2005;26:646-649. (Pubitemid 41073406)
7. Carey AJ, Saiman L, Polin RA. Hospital-acquired infections in the NICU: epidemiology for the new millennium. Clin Perinatol. 2008;35:223-249. (Pubitemid 351246702)
8. Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis. 2008;21:344-349.
9. Rubin LG, Sánchez PJ, Siegel J, et al. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics. 2002;110:e42.
10. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, et al. Pediatric Prevention Network. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J. 2005;24:766-773. (Pubitemid 41324883)
11. Arnold C, Clark R, Bosco J, et al. Variability in vancomycin use in newborn intensive care units determined from data in an electronic medical record. Infect Control Hosp Epidemiol. 2008;29:667-670. (Pubitemid 352009395)
12. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J. 2009;28:1047-1051.
13. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. MMWR Recom Rep. 1995;44(RR-12):1-13.
14. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics. 2000;106:1387-1390.
15. Lawrence SL, Roth V, Slinger R, et al. Cloxacillin versus vancomycin for presumed late-onset sepsis in the Neonatal Intensive Care Unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr. 2005;5:49.
16. Krediet TG, Jones ME, Gerards LJ, et al. Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates. Pediatrics. 1999;103:E29.
17. Gerber SI, Jones RC, Scott MV. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol. 2006;27:139-145. (Pubitemid 43384760)
18. Carey AJ, Duchon J, Della-Latta P, et al. The epidemiology of methicillin susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007. J Perinatol. 2010;30:135-139.
19. Stark AR; American Academy of Pediatrics Committee on Fetus and Newborn. Levels of neonatal care. Pediatrics. 2004;114:1341-1347. (Pubitemid 41647699)
20. American Academy of Pediatrics. Principles of appropriate use of vancomycin. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:742-743.
21. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177. (Pubitemid 46084814)
22. Isaacs D. Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed 2006;91:F72-F74. (Pubitemid 43059208)
23. Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117:1979-1987. (Pubitemid 46071242)
24. Gregory ML, Eichenwald EC, Puopolo KM. Seven year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics. 2009;123:e790-796.